(Q62062271)

English

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Randomised, Double-blinded, Multiple-dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC9204-1706 in Subjects Being Overweight or With Obesity (English)

0 references

0 references

0 references

United States of America

0 references

start time

12 September 2018

0 references

end time

5 September 2019

0 references

number of participants

60

0 references

clinical trial phase

phase I clinical trial

0 references

research site

Novo Nordisk

0 references

research subject recruitment status

completed

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03661879

0 references

(Q62062271)

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)